IFP Advisors Inc grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 20.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,192 shares of the exchange traded fund’s stock after purchasing an additional 3,590 shares during the quarter. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $3,354,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the stock. Waverly Advisors LLC increased its position in SPDR S&P Biotech ETF by 29.6% during the second quarter. Waverly Advisors LLC now owns 3,524 shares of the exchange traded fund’s stock worth $558,000 after purchasing an additional 805 shares during the last quarter. HighTower Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 10.7% in the 2nd quarter. HighTower Advisors LLC now owns 90,861 shares of the exchange traded fund’s stock valued at $14,379,000 after purchasing an additional 8,780 shares during the last quarter. Tobias Financial Advisors Inc. acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at about $214,000. Kingsbury Capital Investment Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $245,000. Finally, Kintra Wealth LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $202,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA XBI opened at $156.82 on Friday. The company has a market capitalization of $10.24 billion, a P/E ratio of 11.47 and a beta of 0.84. The company has a 50 day simple moving average of $158.35 and a 200-day simple moving average of $141.62. SPDR S&P Biotech ETF has a 1 year low of $92.64 and a 1 year high of $169.89.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
